Orchid Pharma Limited Share Price Bombay S.E.
Equities
524372
INE191A01019
Pharmaceuticals
Sales 2024 * | 844.53Cr 10Cr | Sales 2025 * | 1.08TCr 13Cr | Capitalization | 5.56TCr 67Cr |
---|---|---|---|---|---|
Net income 2024 * | 91Cr 1.09Cr | Net income 2025 * | 142.2Cr 1.71Cr | EV / Sales 2024 * | 6.46 x |
Net cash position 2024 * | 105.6Cr 1.27Cr | Net cash position 2025 * | 119.7Cr 1.44Cr | EV / Sales 2025 * | 5.05 x |
P/E ratio 2024 * |
60.8
x | P/E ratio 2025 * |
39.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.03% |
Latest transcript on Orchid Pharma Limited
Managers | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 31/20/31 |
Director of Finance/CFO | - | 29/20/29 | |
Kapil Dayya
CMP | Compliance Officer | - | 16/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 31/20/31 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 31/20/31 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 31/20/31 |
1st Jan change | Capi. | |
---|---|---|
+38.33% | 72TCr | |
+34.28% | 59TCr | |
-4.34% | 37TCr | |
+20.23% | 33TCr | |
+2.44% | 28TCr | |
+17.02% | 24TCr | |
+9.31% | 21TCr | |
-5.07% | 21TCr | |
+0.04% | 17TCr |